Clinical Trials Logo

Clinical Trial Summary

Prognostic factors for breast cancer beyond stage at diagnosis and tumor characteristics have not been well studied. Of special interest are lifestyle factors that can be modified by women after diagnosis to increase disease-free survival. Green tea is rich in polyphenols consisting primarily of epicatechins, epigallocatechin, epicatechin gallate, and epigallocatechin gallate (EGCG). The investigators hypothesize that there will be a reduction in proliferation and/or an increase in apoptosis in association with short-term EGCG treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00949923
Study type Interventional
Source University of Southern California
Contact
Status Completed
Phase N/A
Start date May 7, 2008
Completion date June 6, 2016

See also
  Status Clinical Trial Phase
Completed NCT03304171 - Overall Diet Quality and Breast Cancer Risk N/A